| | Group : Standards; Antibodies; Pharmaceutical/API Drug Imp Group : Standards; Carbohydrates and Oligosaccharides; Co Group : Standards; Carbohydrates and Oligosaccharides; So Group : Standards; Carbohydrates and Oligosaccharides; St Group : Standards; Catalyst; Miscellaneous; Pharmaceutical Group : Standards; Chiral Molecules; Amino Acids/Peptides; Group : Standards; Chiral Molecules; Amino Acids; Carbohy Group : Standards; Chiral Molecules; Carbohydrates and Ol Group : Standards; Chiral Molecules; Molecular Biology; Ne Group : Standards; Chiral Molecules; Molecular Biology; Ph Group : Standards; Chiral Molecules; Steroids; Solutions; Group : Standards; Dyes; Environmental Standards, Mutagen Group : Standards; Enzyme Activators and Inhibitors; Glyco Group : Standards; Enzyme Activators and Inhibitors; Pharm (3S,6S,7S,9S,12S)-7-HYDROXY-N1,N14-DIMETHYL-3,12-BIS(1-METHYLETHYL)-N1,N14-BIS[[2-(1-METHYLETHYL)-4-THIAZOLYL]METHYL]-4,11-DIOXO-6,9-BIS(PHENYLMETHYL)-2,5,10,13-TETRAAZATETRADECANEDIAMIDE CAS:869368-48-9 Formula: C46 H66 N8 O5 S2 TRC-H825640-100MG H825640 875.2 (6S,12BR)-6-(1,3-BENZODIOXOL-5-YL)-2,3,7,12B-TETRAHYDRO-2-METHYL-PYRAZINO[1',2':1,5]PYRROLO[3,4-B]QUINOLINE-1,4,12(6H)-TRIONE CAS:531500-48-8 Formula: C22H17N3O5 TRC-B200035-25mg B200035 403.39 (6S,12BR)-6-(1,3-BENZODIOXOL-5-YL)-2,3,7,12B-TETRAHYDRO-2-METHYL-PYRAZINO[1',2':1,5]PYRROLO[3,4-B]QUINOLINE-1,4,12(6H)-TRIONE CAS:531500-48-8 Formula: C22H17N3O5 TRC-B200035-2.5mg B200035 403.39 |